ArticleOncogene2003

Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.

Farida Jhabvala-Romero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.